Dry Needling for Achilles Tendinopathy

Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Brooke Army Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to determine if adding ultrasound-guided tendon dry needling with mechanical needle stimulation to a standard heavy, slow resistance (HSR) exercise program improves outcomes for individuals with chronic midportion Achilles tendinopathy. Achilles tendinopathy is a common condition causing long-term pain and reduced function in the main heel tendon.

All participants in this study will engage in a standardized 12-week physical therapy exercise program targeting the calf and Achilles tendon complex. Exercises are performed three times per week, combining supervised clinic sessions and home exercises, with the workload safely progressing over time based on individual performance and pain monitoring.

In addition to the standard exercise program, participants will be randomly assigned to one of two groups to evaluate the effect of the dry needling procedure. The experimental group will receive 6 sessions of ultrasound-guided tendon dry needling over approximately 6 weeks, where fine needles are inserted into the affected area of the tendon and gently rotated under ultrasound visualization to stimulate tissue remodeling. The control group will receive an identical schedule of "sham" (placebo) needling, using a toothpick device inside a needle sheath to mimic the sensation without actually penetrating the skin.

Improvements in pain, physical function, and physical performance (such as a heel-rise endurance test) will be recorded at baseline, 6 weeks, 12 weeks, and 26 weeks. Ultrasound imaging will also be used to evaluate structural changes inside the tendon, such as thickness and blood flow. The primary objective is to compare changes in Achilles-specific pain and function scores between the two groups at the conclusion of the 12-week intervention to determine if actual dry needling provides superior therapeutic benefits compared to exercise alone.

Who Is on the Research Team?

BH

Benjamin Hando, DSc, PhD

Principal Investigator

Army-Baylor Doctoral Fellowship in Orthopedic Manual Physical Therapy

Are You a Good Fit for This Trial?

This trial is for adults aged 18-64 who have had pain in one or both Achilles tendons for at least 6 weeks, especially when running, jumping, or walking. Participants must speak English.

Inclusion Criteria

I feel pain in my Achilles when I run, jump, or walk.
I am between 18 and 64 years old.
English-speaking
See 2 more

Exclusion Criteria

I have had an Achilles tendon rupture or surgery before.
I have pain only where my Achilles tendon attaches to my heel.
Needle phobia
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-week standardized physical therapy exercise program targeting the calf and Achilles tendon complex, with additional ultrasound-guided tendon dry needling or sham needling for 6 weeks.

12 weeks
3 visits per week (1 in-person, 2 home sessions)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6, 12, and 26 weeks.

14 weeks
3 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Dry Needling

Trial Overview

The study tests whether adding ultrasound-guided dry needling to a standard exercise program helps people with mid-portion Achilles tendon pain more than exercise alone. Participants are randomly assigned to real or sham (placebo) needling while all do the same exercises.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Dry Needling GroupExperimental Treatment1 Intervention
Group II: Sham Needling GroupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brooke Army Medical Center

Lead Sponsor

Trials
134
Recruited
28,100+